[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
FW: Inst. of Med. Panel Recommendations
Hi All:
I received this post from a friend that belongs to a radiobiology list and I
thought RADIATORS might be interested. I apologize for the rather poor text
format.
Andrés
----------
From: Sauna Malay
To: Sinisterra,Andres
Subject: Inst. of Med. Panel Recommendations
Date: Tuesday, March 12, 1996 9:45PM
Hi Andre,
This was posted to the radiobiology list. I thought you might be interested.
>From: "Bob Etcher" <RATCHER@creative.vprua.uab.edu>
>Organization:
>To: dose-net@orau.gov, radiobiology@mailbase.ac.uk,
medphys@CMS.CC.WAYNE.EDU
>Date: Tue., 12 Mar 1996 17:29:27 CST+6CDT
>Subject: Inst. of Med. Panel Recommendations
>Reply-to: ratcher@creative.vprua.uab.edu
>Priority: normal
>X-mailer: Pegasus Mail/Mach (v2.1.2)
>X-List: radiobiology@mailbase.ac.uk
>X-Sub: To leave, send text 'leave radiobiology'
> to mailbase@mailbase.ac.uk
>Sender: radiobiology-request@mailbase.ac.uk
>Precedence: list
>
>The Nuclear Regulatory Commission funded a study by the
>Institute of Medicine/National Academy of Sciences on the
>regulation of medical activities by the NRC. The panel
>published its report recently, though it is not available
>yet. The report is copyrighted, so you will have to buy
>it from the NAS. I have my problems with a federally funded
>study being made available that way, but that isn't the point
>of this post.
>
>Several people on these lists have asked me to post the
>committees recommendations since they are an interesting
>model for the ultimate actions that one might expect based
>upon the Health Physics Society's recent position paper on
>low dose and health risks.
>
>Here are the recommendations.
>
>
>Summary of Recommendations to the Congress, the Nuclear Regulatory
>Commission, the Conference of Radiation Control Program Directors, and the
>States
>
>The committee recommends that:
>
> A1. Congress eliminate all aspects of the NRC's Medical Use
Program,
>10
>CFR Part 35, and those regulatory activities conducted under 10 CFR Part 20
>that are applicable to medical uses.
> A2. Congress direct the Secretary of Health and Human Services to
>support, coordinate, and encourage the following activities involving
>regulation of all ionizing radiation in medicine:
>
> a. supporting the operation of the Conference of
>Radiation Control
>Program Directors;
> b. providing a venue for the review and evaluation of
>Suggested State
>Regulation for Control of Radiation;
> c. assisting states in implementation of their
regulation;
> d. aiding in assessment of the effectiveness of state
>programs through
>the collection and analysis of data;
> e. helping develop survey methods by which the rate of
>adverse events for
>a wide range of procedures and devices might be measured;
> f. monitoring the effects of deregulation;
> g. enhancing training and standards for health care
>personnel; and
> h. investigating future significant radiation medicine
>incidents.
>
> B1. The NRC immediately relax enforcement of 10 CFR 35.32 and
35.33
>through its present mechanisms.
> B2. The NRC initiate formal steps under the Administrative
Procedure
>Act
>to revoke Part 35 in its entirety, if Congress fails to act within two
>years in response to the two recommendations to Congress stated above.
> B3. The NRC separate the costs of formulating regulations from the
>costs
>of administering those regulations.
>
> C1. The Conference of Radiation Control Program Directors
incorporate
>into its Suggested State Regulations for Control of Radiation any relevant
>concepts from 10 CFR Part 35 that are not already integrated in those
>suggested regulations.
> C2. All state legislatures enact enabling legislation to
incorporate
>the
>regulation of reactor-generated byproducts into existing state regulatory
>programs.
> C3. The Conference of Radiation Control Program Directors and the
>states
>continually reevaluate their regulations and procedures pertaining to
>radiation medicine to ensure congruence with evolving scientific
>understanding of radiation bioeffects and to be in accord with advances in
>knowledge regarding benefits and risks related to medical and biomedical
>research uses of ionizing radiation in medicine.
>
>
>The report is very long. A copy of the executive summary would suffice all
>but the most masochistic reader.
>
>Bob Atcher
>Cardiovascular Disease Div.
>Dept. of Medicine
>Univ. of Alabama at Birmingham
>
>
Sanjay M. Mallya BDS, MDS
Div. of Oral & Maxillofacial Radiology
Univ. of Conn. Health Center
Farmington, CT 06030-1605
Tel:(860) 679-3167
Fax: (860) 679-4760
smallya@neuron.uchc.edu